Bogdanov, AV,
Voloshina, AD,
Sapunova, AS,
Kulik, NV,
Bukharov, SV,
Dobrynin, AB,
Voronina, JK,
Terekhova, NV,
Samorodov, AV,
Pavlov, VN,
Mironov, VF (2022) and sodium heparin
drugs. It has been shown by UV spectroscopy and fluorescence microscopy that the mechanism
Ivanova, E.,
Asadullina, D.,
Rakhimov, R.,
Izmailov, A.,
Izmailov, Al.,
Gilyazova, G.,
Galimov, Sh.,
Pavlov, V.,
Khusnutdinova, E.,
Gilyazova, I. (2022) in the formation of tumor resistance to ICIs
drugs and therapy. We performed exosomal miRNA-146a expression
Tyurin, Anton V.,
Akhiyarova, Karina E.,
Valishin, Damir A.,
Sadretdinova, Lidiya D.,
Khusainova, Leonora N.,
Zagidullin, Naufal S.,
Gantseva, Khalida K.,
Pavlov, Valentin N. (2022) storm in monotherapy was insufficient. Based on CT data, both target
drugs did not stop the progression
Asadi-Pooya, AA,
Trinka, E,
Brigo, F,
Hingray, C,
Karakis, I,
Lattanzi, S,
Valente, KD,
Contreras, G,
Turuspekova, ST,
Kishk, NA,
Aljandeel, G,
Farazdaghi, M,
Lopez, YC,
Kissani, N,
Triki, C,
Kramer, G,
Surges, R,
Mesraoua, B,
Yu, HY,
Daza-Restrepo, A,
Alsaadi, T,
Al-Asmi, A,
Kutlubaev, MA,
Pretorius, C,
Jusupova, A,
Khachatryan, SG,
Ranganathan, LN,
Ashkanani, A,
Tomson, T,
Gigineishvili, D (2022) -clonic seizures, or with
drug-resistant epilepsy. The propensity to tell all patients with epilepsy (PWE) about
, the only effective
drugs for the treatment of tumor syndrome in NF1 are inhibitors of mitogen
Pashirova, T.N.,
Shaihutdinova, Z.M.,
Vandyukov, A.E.,
Lyubina, A.P.,
Amerhanova, S.K.,
Voloshina, A.D.,
Samorodov, A.V.,
Souto, E.B.,
Mironov, V.F.,
Mironov, V.F. (2022) -bonds with
drugs (niclosamide and piperine) and displays a good selectivity index toward fungi Candida albicans
ПРИМЕНЕНИЕ ГИБРИДНОГО ХИРУРГИЧЕСКОГО МЕТОДА В ЛЕЧЕНИИ ОСТРОГО ДЕСТРУКТИВНОГО ПИЕЛОНЕФРИТААнаньев, В.А.,
Павлов, В.Н.,
Пушкарёв, А.М.,
Ananev, V.A.,
Pavlov, V.N.,
Pushkarev, A.M. (2022) with drainage of the retroperitoneal space and
drug correction of kidney
circulation by endovascular access